Mark Perreault

Mark Perreault is the director of membrane application development for TangenX technology at Novasep

Articles

An Economic Analysis of Single-Use Tangential Flow Filtration for Biopharmaceutical Applications

Single-use TFF offers the greatest savings in clinical and contract manufacturing, where the scale is low and changeovers are frequent.